Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostaglandin E-major urinary metabolite as a noninvasive surrogate marker for infantile necrotizing enterocolitis.
Konishi KI, Yoshida M, Nakao A, Tsuchiya K, Tsurisawa C, Ichiki K, Takeda T, Hisaeda Y, Hirota A, Amagata S, Odashima T, Yokomori K, Ishida K, Matsuura M, Ito S, Fujiwara M, Nakahara S. Konishi KI, et al. Among authors: ishida k. J Pediatr Surg. 2019 Aug;54(8):1584-1589. doi: 10.1016/j.jpedsurg.2018.08.044. Epub 2018 Sep 13. J Pediatr Surg. 2019. PMID: 30291024
Contrast-enhanced ultrasonographic image of gangrenous gallbladder.
Yashima Y, Tsujino T, Nakahara S, Ishida K, Nakata R, Isayama H, Koike K. Yashima Y, et al. Among authors: ishida k. J Med Ultrason (2001). 2011 Oct;38(4):239. doi: 10.1007/s10396-011-0316-9. Epub 2011 Sep 9. J Med Ultrason (2001). 2011. PMID: 27278591 No abstract available.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Takano T, Masuda N, Ito M, Inoue K, Tanabe Y, Kawaguchi K, Yasojima H, Bando H, Nakamura R, Yamanaka T, Ishida K, Aruga T, Yanagita Y, Tokunaga E, Aogi K, Ohno S, Kasai H, Kataoka TR, Morita S, Toi M. Takano T, et al. Among authors: ishida k. Breast Cancer Res Treat. 2024 May 20. doi: 10.1007/s10549-024-07333-7. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38767786
An Enzymatic Prodrug-like Route to Thio and Selenoamides.
Ishida K, Litomska A, Dunbar KL, Hertweck C. Ishida K, et al. Angew Chem Int Ed Engl. 2024 May 15:e202404243. doi: 10.1002/anie.202404243. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38747847
2,754 results